NANOBIOTIX (EPA:NANO) NANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial and New Exploratory Analysis From Completed Phase 1 Head and Neck Cancer Trial at ESMO 2023
Transparency directive : regulatory news
23/10/2023 08:00